WELCOME to epgonline.org

Welcome to epgonline.org, a free online source of credible and independent scientific content intended for healthcare professionals in the United Kingdom that brings all the medical information you need into one place, providing education and guidance to help with the diagnosis and treatment of your patients.

This website provides:

  • Drug information, categorised using the ATC Classification System, providing indication, dosage, administration and precautions.
  • Specialty and disease information, categorising specialties and diseases using the ICD-10 classification, with further insight found in the Disease Focus area.
  • The Horizons series of articles, written by our team of specialists, that ask what the future of healthcare holds, evaluating emerging trends to provide expert insight.
  • The latest news to keep you up-to-date with current advancements in drug development, advocacy and awareness, industry mergers and acquisitions, clinical trial progression and congress information.
  • Recent opinion articles shared with us by healthcare professionals to express their views and experiences.
  • A wide variety of accredited internal and external CME modules and courses, designed to educate on the latest care strategies for specific conditions.
  • The latest studies, trials and guidelines from global publications provide a comprehensive collection of current and past developments in medicine, helping you to provide best practice.
  • Medical applications that deliver creative solutions to aid in the diagnosis and treatment of your patients.
  • Specialist educational microsites, or Learning Zones, each devoted to self-directed medical education surrounding a specific disease, condition or procedure.

Registration is quick and simple, giving you unlimited access to all content and features, allowing you to save pages, comment on your favourite articles and access the personalised dashboard.

Latest News

Added 21 hours ago Drug news

NICE refuses to recommend Kymriah to treat diffuse large B-cell lymphoma.- Novartis

The National Institute for Health and Care Excellence (NICE), in a draft ruling, has rejected Kymriah (tisagenlecleucel) for use in...

Added 21 hours ago Drug news

Phase III post-hoc analyses of Vyndaqel shows benefits in ATTR-ACT.- Pfizer.

Pfizer announced that additional sensitivity and post-hoc analyses from the Tafamidis Phase III Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) study provide further...

Added 21 hours ago Drug news

European Commission approves Ilumetri to treat psoriasis.- Almirall

Almirall, S.A. has announced that the European Commission (EC) has approved Ilumetri (tildrakizumab), a humanized, high-affinity IL-23p19 monoclonal antibody, for...

Selected congress insight

The Asthma Report

ERS 2018 | Day 1 Highlights

Posted 4 days ago

News and insight from our reporting team at ERS 2018, who looked at one of the sessions covering novel pharmacological therapies in airway disease. 

The Asthma Report

ERS 2018 | Day 2 Highlights

Posted 5 days ago

A summary of the sessions from the State of the art airways programme at the European Respiratory Society Congress 2018.

Antithrombosis News

ESC 2018: Antithrombosis News congress highlights

Posted 23 days ago

Follow us on Facebook or Twitter now to get more ESC 2018 highlights and congress reports.

Antithrombosis News

ESC 2018 Day 1 highlights: National prescribing and adverse event rates of patients at risk of stroke with non-valvular AF.

Posted 27 days ago

Stroke prevention for patients with non-valvular atrial fibrillation is a key topic at ESC 2018. Follow us on Facebook or Twitter now to get more ESC 2018 highlights and congress reports.